FEATURES OF EXPRESSION OF KI-67 AND NFE2L2 IN TARGET ORGANS OF MELANOMA METASTASIS IN PREMETASTATIC PHASE
- Authors: Sergeeva O.N1, Palkina N.V1, Aksenenko M.B1, Komina A.V1, Sergeeva E.Y.1, Ruksha T.G.1
-
Affiliations:
- Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky
- Issue: Vol 21, No 2 (2018)
- Pages: 68-71
- Section: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/37333
- DOI: https://doi.org/10.18821/1560-9588-2018-21-2-68-71
- ID: 37333
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. N Sergeeva
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk,660022, Russian Federation
N. V Palkina
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk,660022, Russian Federation
M. B Aksenenko
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk,660022, Russian Federation
A. V Komina
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk,660022, Russian Federation
E. Yu Sergeeva
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk,660022, Russian Federation
Tatiana G. Ruksha
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky
Email: tatyana_ruksha@mail.ru
MD, PhD, DSc., Head of Department of pathophysiology, KrasSMU n.a. prof. V.F. Voyno-Yasenetsky, Krasnoyarsk, 660022, Russian Federation Krasnoyarsk,660022, Russian Federation
References
- Tas F. Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. J. Oncol. 2012; 2012: 647684. doi: 10.1155/2012/647684
- Жуковец А.Г. Современные принципы и перспективы лечения меланомы кожи. Онкологический журнал. 2015; 36(4): 69-76
- Chew V., Toh H.C., Abastado J.P. Immune microenvironment in tumor progression: characteristics and challenges for therapy. J. Oncol. 2012; 2012: 608406. doi: 10.1155/2012/608406.
- Son В., Lee S., Youn H., Kim E., Kim W., Youn B. The role of tumor microenvironment in therapeutic resistance. Oncotarget. 2017; 8(3): 3933-45. doi: 10.18632/oncotarget.13907.
- Zhang L., Hu Y., Xi N., Song J., Huang W., Song S., et al. Partial oxygen pressure affects the expression of prognostic biomarkers HIF-1 alpha, Ki-67, and CK20 in the microenvironment of colorectal cancer tissue. Oxid. Med. Cell. Longev. 2016; 2016: 1204715. doi: 10.1155/2016/1204715.
- Park S.A., Surh Y.J. Modulation of tumor microenvironment by chemopreventive natural products. Ann. N.Y. Acad. Sci. 2017; 1401(1): 65-74. doi: 10.1111/nyas.13395.
- Yang L., Lin P.C. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression. Semin. Cancer Biol. 2017; 47: 185-95. doi: 10.1016/j.semcancer.2017.08.001.
- Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer. 2009; 9(4): 285-93. doi: 10.1038/nrc2621.
- Winking H., Gerdes J., Traut W. Expression of the proliferation marker Ki-67 during early mouse development. Cytogenet. Genome Res. 2004; 105(2-4): 251-6. doi: 10.1159/000078196.
- Uguen A., Talagas M., Costa S., Duigou S., Bouvier S., De Braekeleer M., Marcorelles P. A p16 Ki-67 HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma. Diagn. Pathol. 2015; 10: 195. doi: 10.1186/s13000-015-0431-9.
- Шишкин М.А. Особенности иммуногистохимической экспрессии маркера клеточной пролиферации Ki-67 в опухолевых и стромальных клетках колоректальной аденокарциномы. Патологiя. 2016; 37(2): 76-81
- Hintsala H.R., Haapasaari K.M., Soini Y., Karihtala P. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2’-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma. Histol. Histopathol. 2017; 32(2): 129-36. doi: 10.14670/HH-11-778.
- Hintsala H.R., Jokinen E., Haapasaari K.M., Moza M., Ristimaki A., Soini Y., et al. Nrf2/Keap1 pathway and expression of oxidative stress lesions 8-hydroxy-2’-deoxyguanosine and nitrotyrosine in melanoma. Anticancer Res. 2016; 36(4): 1497-506.
- Jaramillo M.C., Zhang D.D. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 2013; 27(20): 2179-91. doi: 10.1101/gad.225680.113.
- Ruksha T.G., Aksenenko M.B., Papadopoulus V. Role of translocator protein in melanoma growth and progression. Arch. Dermatol. Res. 2012; 304(10): 839-45. doi: 10.1007/s00403-012-1294-5.
- Costache M., Stoica A., Contolenco A., Costache D., Cirstoiu C., Simionescu O., George S. Metastatic melanoma in the femur - case report with review of literature: a pathologists point of view. Maedica (Buchar). 2014; 9(1): 62-7.
- Mervic L. Time course and pattern of metastasis of cutaneous melanoma differ between men and women. PLoS One. 2012; 7(3): e32955. doi: 10.1371/journal.pone.0032955
- Damsky W.E., Rosenbaum L.E., Bosenberg M. Decoding melanoma metastasis. Cancers (Basel). 2011; 3(1): 126-63. doi: 10.3390/cancers3010126.
- Аксененко М.Б., Шестакова Л.А., Рукша Т.Г. Особенности метастазирования перевиваемой меланомы В16 после ингибирования активности ММП-9. Сибирский онкологический журнал. 2012; 11(1): 31-5
- Sobecki M., Mrouj K., Camasses A., Parisis N., Nicolas E., Lleres D., et al. The cell proliferation antigen Ki-67 organises heterochromatin. Elife. 2016; 5: e13722. doi: 10.7554/eLife.13722.
- Ilmonen S., Hernberg М., Pyrhonen S., Tarkkanen J., Asko-Seljavaara S. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma. Melanoma Res. 2005; 15(5): 375-81.
- Bussard K.M., Mutkus L., Stumpf K., Gomez-Manzano C., Marini F.C. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016; 18(1): 84. doi: 10.1186/s13058-016-0740-2.
- Beyer T.A., Xu W., Teupser D., auf dem Keller U., Bugnon P., Hildt E., et al. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J. 2008; 27(1): 212-23. doi: 10.1038/sj.emboj.7601950.
- Murakami S., Motohashi H. Roles of Nrf2 in cell proliferation and differentiation. Free Radic. Biol. Med. 2015; 88(Pt B): 168-78. doi: 10.1016/j.freeradbiomed.2015.06.030.
- Плешкан В.В., Зиновьева М.В., Свердлов Е.Д. Меланома: Поверхностные маркеры как первый «порт» адресной доставки терапевтических генов при многоуровневой генной терапии. Молекулярная биология. 2011; 45(3): 416-33
![](/img/style/loading.gif)